⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MLTX News
MoonLake Immunotherapeutics Class A Ordinary Shares
Did You Lose Money on MoonLake Immunotherapeutics (MLTX)? Levi & Korsinsky Urges Investors to Act Before December 15, 2025
accessnewswire.com
MLTX
MLTX Deadline: MLTX Investors with Losses in Excess of $100K Have Opportunity to Lead MoonLake Immunotherapeutics Securities Fraud Lawsuit
prnewswire.com
MLTX
MLTX INVESTOR LOSSES: Lose Money on MoonLake Immunotherapeutics? Contact BFA Law before December 15 Securities Class Action Deadline
globenewswire.com
MLTX
MLTX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that MoonLake Immunotherapeutics Shareholders Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
MLTX
Did You Lose Money on MoonLake Immunotherapeutics (MLTX)? Levi & Korsinsky Urges Investors to Act Before December 15, 2025
accessnewswire.com
MLTX
Pomerantz LLP Notifies Investors of Class Action Lawsuit Against MoonLake Immunotherapeutics – MLTX
accessnewswire.com
MLTX
MLTX 9-DAY DEADLINE ALERT: MoonLake Immunotherapeutics (MLTX) Faces Securities Class Action After Company Reported Disastrous Phase 3 Trial Data For Sole Drug Candidate -- Hagens Berman
globenewswire.com
MLTX
MLTX SECURITIES ALERT: BFA Law Reminds MoonLake Immunotherapeutics Investors with Losses of Important December 15 Securities Class Action Deadline
newsfilecorp.com
MLTX
התראת מועד חשוב לתביעה נגד MLTX: רוזן, עורכי דין מקצועיים למשפטים, מעודדים את משקיעי MoonLake Immunotherapeutics להשיג ייעוץ משפטי לפני המועד החשוב של 15 בדצמבר בתביעה ייצוגית בניירות ערך – MLTX
globenewswire.com
MLTX
Pomerantz LLP Notifies Investors of Class Action Filing Against MoonLake Immunotherapeutics – MLTX
accessnewswire.com
MLTX